Imported Cutaneous Larva Migrans: Epidemiological, Clinical, and Therapeutic Aspects Analyzed in a Referral Tropical Medicine Unit in Barcelona
The American Journal of Tropical Medicine and Hygiene · 2025
DOI: 10.4269/ajtmh.24-0856 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, 2025. Verfasst von David López-Neila und 11 weiteren Autor:innen. Beteiligte Einrichtung: International Health Unit Vall d'Hebron-Drassanes,Department of Infectious Diseases, Vall d'Hebron University Hospital, PROSICS Barcelona, Barcelona,…. Hauptthemen laut MEDLINE: Communicable Diseases, Imported, Larva Migrans. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Cutaneous larva migrans (CLM) is a clinical syndrome typically found in tropical and subtropical regions. The objective of the study is to describe the epidemiological, clinical, and therapeutic characteristics of patients with CLM acquired during international travel. This retrospective observational study analyzes CLM cases treated at an international health unit in Spain. Sociodemographic, clinical, laboratory, and treatment-related data were collected. Overall, 107 cases were diagnosed, 63 (58.9%) of them in women, with a mean age of 32.6 years. Most frequent geographic regions of CLM acquisition were Southeast Asia (38 cases, 35.5%) and South America (28, 26.2%). Patients had a median of one skin lesion (range 1–11) located mainly in the lower extremities (83, 77.6%). Treatment was administered in 105 cases (98.1%), with albendazole used in 88 (83.8%), ivermectin in nine (8.6%), mebendazole in six (5.7%), and two cases lacking drug information (1.9%). Among treated cases, clinical resolution was achieved in 88 (83.8%) patients. Symptoms persisted in 17 (16.2%) cases, and recurrence was observed in 14 (13.3%) cases. A total of 26 (24.8%) patients required re-treatment with either albendazole or ivermectin (61.5% and 38.5%, respectively). The resolution rates for ivermectin, albendazole, and mebendazole were 88.9%, 88.6%, and 0.0%, respectively. CLM is a common syndrome in certain geographic regions and is more frequently diagnosed in international travelers. A thorough epidemiological assessment, along with a detailed medical history and physical examination, facilitates early diagnosis and treatment. Currently, ivermectin and albendazole appear to achieve the highest cure rates with lower recurrence rates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- International Health Unit Vall d'Hebron-Drassanes,Department of Infectious Diseases, Vall d'Hebron University Hospital, PROSICS Barcelona, Barcelona, Spain.
- Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
Zitieren
APA
López-Neila, D., Salvador, F., Martínez-Campreciós, J., Aznar, M. L., Espinosa-Pereiro, J., Oliveira-Souto, I., Bosch-Nicolau, P., Pou, D., Sánchez-Montalvá, A., Serre-Delcor, N., Treviño, B., & Molina, I. (2025). Imported Cutaneous Larva Migrans: Epidemiological, Clinical, and Therapeutic Aspects Analyzed in a Referral Tropical Medicine Unit in Barcelona. The American Journal of Tropical Medicine and Hygiene. https://doi.org/10.4269/ajtmh.24-0856
Vancouver
López-Neila D, Salvador F, Martínez-Campreciós J, Aznar ML, Espinosa-Pereiro J, Oliveira-Souto I, et al. Imported Cutaneous Larva Migrans: Epidemiological, Clinical, and Therapeutic Aspects Analyzed in a Referral Tropical Medicine Unit in Barcelona. The American Journal of Tropical Medicine and Hygiene. 2025. doi:10.4269/ajtmh.24-0856
BibTeX
@article{LpezNeila2025,
author = {López-Neila, David and Salvador, Fernando and Martínez-Campreciós, Joan and Aznar, María Luisa and Espinosa-Pereiro, Juan and Oliveira-Souto, Inés and Bosch-Nicolau, Pau and Pou, Diana and Sánchez-Montalvá, Adrián and Serre-Delcor, Núria and Treviño, Begoña and Molina, Israel},
title = {Imported Cutaneous Larva Migrans: Epidemiological, Clinical, and Therapeutic Aspects Analyzed in a Referral Tropical Medicine Unit in Barcelona},
journal = {The American Journal of Tropical Medicine and Hygiene},
year = {2025},
doi = {10.4269/ajtmh.24-0856}
}
EUVIMED